Missing/wrong data?
Log in to edit
Biomarker analyses in CLEOPATRA: a phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer
scientific article published on 20 October 2014
Author/s
author: Javier Cortes, Sandra M. Swain, Seock-Ah Im, José Baselga
Work details
Publication date
October 20, 2014
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.